Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma

A Moran; S Ramakrishnan; C Borg; C Connolly; S Couillard; C Mwasuku; I Pavord; T Hinks; L Lehtimäki

doi:10.1183/13993003.congress-2020.2252

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma

A Moran
, S Ramakrishnan
, C Borg
, C Connolly
, S Couillard
, C Mwasuku
, I Pavord
, T Hinks
, L Lehtimäki

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Number of pages	2
DOIs	https://doi.org/10.1183/13993003.congress-2020.2252
Publication status	Published - 7 Sept 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1183/13993003.congress-2020.2252

Cite this

@conference{3eab27e3357342a283e90e777463a631,

title = "Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma",

keywords = "Asthma - management, Severe asthma",

author = "A Moran and S Ramakrishnan and C Borg and C Connolly and S Couillard and C Mwasuku and I Pavord and T Hinks and L Lehtim{\"a}ki",

year = "2020",

month = sep,

day = "7",

doi = "10.1183/13993003.congress-2020.2252",

language = "English",

}

TY - CONF

T1 - Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma

AU - Moran, A

AU - Ramakrishnan, S

AU - Borg, C

AU - Connolly, C

AU - Couillard, S

AU - Mwasuku, C

AU - Pavord, I

AU - Hinks, T

AU - Lehtimäki, L

PY - 2020/9/7

Y1 - 2020/9/7

KW - Asthma - management

KW - Severe asthma

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uwapure5-25&SrcAuth=WosAPI&KeyUT=WOS:000606501404247&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1183/13993003.congress-2020.2252

DO - 10.1183/13993003.congress-2020.2252

M3 - Abstract

ER -

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma

UN SDGs

Access to Document

Other files and links

Cite this